All Cosmos Bio-Tech Holding Corp
All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia and internationally. The company offers bio-chemical fertilizers, as well as offers water reutilization services. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In add… Read more
All Cosmos Bio-Tech Holding Corp (4148) - Total Liabilities
Latest total liabilities as of September 2025: NT$698.22 Million TWD
Based on the latest financial reports, All Cosmos Bio-Tech Holding Corp (4148) has total liabilities worth NT$698.22 Million TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
All Cosmos Bio-Tech Holding Corp - Total Liabilities Trend (2010–2024)
This chart illustrates how All Cosmos Bio-Tech Holding Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
All Cosmos Bio-Tech Holding Corp Competitors by Total Liabilities
The table below lists competitors of All Cosmos Bio-Tech Holding Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FnGuide Inc.
KQ:064850
|
Korea | ₩18.96 Billion |
|
JF Technology BHD
KLSE:0146
|
Malaysia | RM15.90 Million |
|
Tsann Kuen Enterprise Co Ltd
TW:2430
|
Taiwan | NT$9.09 Billion |
|
GIIR Inc
KO:035000
|
Korea | ₩282.88 Billion |
|
Helios Energy Limited
PINK:HLEGF
|
USA | $1.73 Million |
|
Vicapsys Life Sciences Inc
PINK:VICP
|
USA | $3.07 Million |
|
Tae Kyung Ind
KO:015890
|
Korea | ₩389.24 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down All Cosmos Bio-Tech Holding Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how All Cosmos Bio-Tech Holding Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for All Cosmos Bio-Tech Holding Corp (2010–2024)
The table below shows the annual total liabilities of All Cosmos Bio-Tech Holding Corp from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$540.27 Million | -37.14% |
| 2023-12-31 | NT$859.54 Million | -31.14% |
| 2022-12-31 | NT$1.25 Billion | +111.10% |
| 2021-12-31 | NT$591.28 Million | +135.39% |
| 2020-12-31 | NT$251.19 Million | +17.60% |
| 2019-12-31 | NT$213.60 Million | -51.32% |
| 2018-12-31 | NT$438.80 Million | +28.24% |
| 2017-12-31 | NT$342.18 Million | -38.41% |
| 2016-12-31 | NT$555.55 Million | -39.88% |
| 2015-12-31 | NT$924.10 Million | -3.50% |
| 2014-12-31 | NT$957.63 Million | +20.87% |
| 2013-12-31 | NT$792.31 Million | +21.99% |
| 2012-12-31 | NT$649.48 Million | +57.92% |
| 2011-12-31 | NT$411.27 Million | +48.53% |
| 2010-12-31 | NT$276.88 Million | -- |